Inivata Inc., a pioneering force in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2014, the company has made significant strides in the field of cancer diagnostics, particularly through its innovative liquid biopsy technology. Inivata's flagship product, InVisionFirst®, offers a non-invasive solution for detecting and monitoring cancer, setting it apart with its ability to provide comprehensive genomic insights from a simple blood sample. With a strong emphasis on precision medicine, Inivata has positioned itself as a leader in the oncology diagnostics market, achieving notable milestones such as strategic partnerships and advancements in clinical research. The company's commitment to improving patient outcomes through advanced diagnostic solutions underscores its reputation as a trusted name in the industry.
We don't have data for Inivata Inc., but we can show you information about their parent organization instead.
View parent company